Search - tctmd.com

Displaying 241 - 260 of 267

Sort: Relevancy | Date

Presentation ECHO 2015

Pitfalls in valvular heart disease assessment

Presenter: Omar Khalique

April 26, 2015

Presentation CATCH-UP 2015

Heart Failure Cardiologist Perspective on Valvular Heart Disease: Focus on Severe AS and Functional MR

Presenter: Melana Yuzefpolskaya

April 25, 2015

Presentation TCT 2014

MitraClip: Current Application and Future Directions

Presenter: Blase A. Carabello, George D. Dangas, Michael J. Rinaldi

September 15, 2014

Presentation TCT 2014

Controversies in Aortic Valve Disease: Challenging Clinical Scenarios (Asymptomatic AS, Low-Flow Low-Gradient AS, and Concomitant CAD)

Presenter: Blase A. Carabello, George D. Dangas

September 15, 2014

Presentation TCT 2014

TAVR On the Horizon: Emerging TAVR Platforms and Technologies

Presenter: Blase A. Carabello, George D. Dangas, Lutz Buellesfeld

September 15, 2014

Presentation TCT 2014

TAVR Update: FDA-Approved Valve Systems

Presenter: Blase A. Carabello, George D. Dangas, Alan C. Yeung

September 15, 2014

Presentation TCT 2014

Guideline Update: Aortic and Mitral Valve Disease and the 2014 AHA/ACC Guideline for Valvular Heart Disease

Presenter: Blase A. Carabello, George D. Dangas, Patrick T. O'Gara

September 15, 2014

Presentation TCT 2014

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Presenter: Zoltan G. Turi, Jason Kovacic

September 14, 2014

Presentation TCT 2014

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

Presenter: Michael J. Lim, Hemal Gada

September 14, 2014

Presentation TCT 2014

Valvular Heart Disease for the Interventionalist

Presenter: Greg L. Kaluza, Manish A. Parikh, Varinder P. Singh, Nicola Corvaja

September 12, 2014

Presentation ECHO 2014

Right Heart Valvular Disease: When to Intervene

Presenter: Linda D. Gillam

April 09, 2014

Presentation TCT 2013

Valvular Heart Disease: Best of EHJ

Presenter: Stephan Windecker

October 30, 2013

Presentation TCT 2013

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

Presenter: Ted Feldman

October 29, 2013

Presentation TCT 2013

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Presenter: Anita Asgar

October 28, 2013

Presentation TCT 2013

Treatment Considerations in Patients with Valvular Heart Disease Requiring PCI: Stent Selection, Pharmacotherapy, and Timing

Presenter: James Hermiller Jr

October 28, 2013

Presentation TCT 2013

Valvular Heart Disease for the Interventionalist

Presenter: Susheel Kodali

October 27, 2013

Presentation ESC 2013

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Findings from the ARISTOTLE Trial

Presenter: Alvaro Avezum

September 03, 2013

Presentation ECHO 2013

When (and how) to use Stress Testing in Valvular Heart Disease

Presenter: Jae K. Oh

April 03, 2013

Presentation ECHO 2013

The Role of 3D Echo in Valvular Heart Disease

Presenter: Linda D. Gillam

April 03, 2013

Presentation ECHO 2013

Right Heart Valvular Disease: When to Intervene

Presenter: Linda D. Gillam

April 03, 2013

Advertisement

Pitfalls in valvular heart disease assessment

Heart Failure Cardiologist Perspective on Valvular Heart Disease: Focus on Severe AS and Functional MR

MitraClip: Current Application and Future Directions

Controversies in Aortic Valve Disease: Challenging Clinical Scenarios (Asymptomatic AS, Low-Flow Low-Gradient AS, and Concomitant CAD)

TAVR On the Horizon: Emerging TAVR Platforms and Technologies

TAVR Update: FDA-Approved Valve Systems

Guideline Update: Aortic and Mitral Valve Disease and the 2014 AHA/ACC Guideline for Valvular Heart Disease

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

Valvular Heart Disease for the Interventionalist

Right Heart Valvular Disease: When to Intervene

Valvular Heart Disease: Best of EHJ

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Treatment Considerations in Patients with Valvular Heart Disease Requiring PCI: Stent Selection, Pharmacotherapy, and Timing

Valvular Heart Disease for the Interventionalist

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Findings from the ARISTOTLE Trial

When (and how) to use Stress Testing in Valvular Heart Disease

The Role of 3D Echo in Valvular Heart Disease

Right Heart Valvular Disease: When to Intervene

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content